This interactive and informative course provides a comprehensive overview of the planning and implementation of phase III and phase IV oncology clinical trials. The course will demonstrate how oncology trials differ in design and conduct from those in other therapy areas. Delegates can learn to design trials to minimize the deficiencies that lead to inappropriate interpretation whilst maximizing the competitive advantage. In addition, delegates will benefit from the perspective and experience of the regulatory bodies on EU oncology directives.
Explore
Membership
